Ozempic doesn't just reduce weight. Research shows GLP-1s also changes how much people spend on food, and the types of food ...
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
Eli Lilly said on Monday it has sued two medical spas for selling unapproved products claiming to contain tirzepatide, the ...
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes ... type 2 diabetes and ...
It has acquired the rights to a suite of weight loss drugs from Chinese firm Sciwind ... Whether Verdiva’s new treatments are a better alternative to the status quo remains to be seen.
Eli Lilly shares dropped after the drugmaker cut its 2024 revenue guidance, citing lower-than-expected demand for its obesity ...
A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.
We meet some of the first NHS patients, as expert says funding everyone eligible would "bankrupt" the service.